FEATURES

Understanding the Complexities of Drug Interactions
Heightened concerns for drug safety in dermatology and general medicine highlight the importance of drug interactions.
By Stephen E. Wolverton, MD

An Introduction to a New Botulinum Toxin Type A Formulation
The first new botulinum toxin type A formulation to reach the US market in nearly two decades presents a new therapeutic option for cosmetic surgeons.
By Evan H. Schlam, MD

Topical Rejuvenation Options for the Hyperpigmentation Patient
Appropriate rejuvenation regimens can actually correct hyperpigmentation and not make it worse.
By Jeanine B. Downie, MD

"Antibiotics" in Dermatology: Facts and Myths
From clearing up long-standing misconceptions to making sense of new therapeutic developments, here are hard facts about antibiotics and their role in patient care.
By Joseph Bikowski, MD

DEPARTMENTS

Editorial Board/Contributors

Recent Developments

Editor's Message

Cosmetics Challenge

Dermatology Q&A

Clinical Focus: Pediatrics

Business Advisor

Practice Development

Therapeutics Update

Take 5